Molecular Imaging of Pancreatic Cancer with Antibodies

Molecular Pharmaceutics

Volumn 13, Issue 1, 2016, Pages 8-24

  England, Christopher G ^a   Hernandez, Reinier ^a   Eddine, Savo Bou Zein ^a   Cai, Weibo ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

antibodies; magnetic resonance imaging (MRI); molecular imaging; optical imaging; pancreatic cancer; photoacoustic tomography (PAT); positron emission tomography (PET); single photon emission computed tomography (SPECT)

Indexed keywords

ANTIBODY;

ARTICLE; CANCER CELL; FLUORESCENCE IMAGING; HUMAN; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PHOTOACOUSTIC TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; PANCREATIC NEOPLASMS; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ANTIBODIES; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84953392444     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00626     Document Type: Article

References (211)

1. Zhang, Z.; Liu, S.; Xiong, H.; Jing, X.; Xie, Z.; Chen, X.; Huang, Y. Electrospun Pla/Mwcnts Composite Nanofibers for Combined Chemo- and Photothermal Therapy Acta Biomater. 2015, 26, 115-123 10.1016/j.actbio.2015.08.003
2. Long, J.; Zhang, Y.; Yu, X.; Yang, J.; LeBrun, D. G.; Chen, C.; Yao, Q.; Li, M. Overcoming Drug Resistance in Pancreatic Cancer Expert Opin. Ther. Targets 2011, 15, 817-828 10.1517/14728222.2011.566216
3. Rahib, L.; Smith, B. D.; Aizenberg, R.; Rosenzweig, A. B.; Fleshman, J. M.; Matrisian, L. M. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States Cancer Res. 2014, 74, 2913-2921 10.1158/0008-5472.CAN-14-0155
4. Tempero, M. A.; Arnoletti, J. P.; Behrman, S.; Ben-Josef, E.; Benson, A. B.; Berlin, J. D.; Cameron, J. L.; Casper, E. S.; Cohen, S. J.; Duff, M.; Ellenhorn, J. D. I.; Hawkins, W. G.; Hoffman, J. P.; Kuvshinoff, B. W.; Malafa, M. P.; Muscarella, P.; Nakakura, E. K.; Sasson, A. R.; Thayer, S. P.; Tyler, D. S.; Warren, R. S.; Whiting, S.; Willett, C.; Wolff, R. A. Pancreatic Adenocarcinoma: Clinical Practice Guidelines in Oncology J. Natl. Compr. Cancer Network 2010, 8, 972-1017
5. Maitra, A.; Hruban, R. H. Pancreatic Cancer Annu. Rev. Pathol.: Mech. Dis. 2008, 3, 157-188 10.1146/annurev.pathmechdis.3.121806.154305
6. Bruenderman, E.; Martin, R. C. 2nd A Cost Analysis of a Pancreatic Cancer Screening Protocol in High-Risk Populations Am. J. Surg. 2015, 210, 409-416 10.1016/j.amjsurg.2014.11.017
7. Agdeppa, E. D.; Spilker, M. E. A Review of Imaging Agent Development AAPS J. 2009, 11, 286-299 10.1208/s12248-009-9104-5
8. Olafsen, T.; Wu, A. M. Antibody Vectors for Imaging Semin. Nucl. Med. 2010, 40, 167-181 10.1053/j.semnuclmed.2009.12.005
9. Hellebust, A.; Richards-Kortum, R. Advances in Molecular Imaging: Targeted Optical Contrast Agents for Cancer Diagnostics Nanomedicine (London, U. K.) 2012, 7, 429-445 10.2217/nnm.12.12
10. Jiang, L.; Tu, Y.; Shi, H.; Cheng, Z. Pet Probes Beyond (18)F-Fdg J. Biomed Res. 2014, 28, 435-446 10.7555/JBR.28.20130196
11. Scott, A. M.; Wolchok, J. D.; Old, L. J. Antibody Therapy of Cancer Nat. Rev. Cancer 2012, 12, 278-287 10.1038/nrc3236
12. Lin, M. Z.; Teitell, M. A.; Schiller, G. J. The Evolution of Antibodies into Versatile Tumor-Targeting Clin. Cancer Res. 2005, 11, 129-138
13. Chames, P.; Van Regenmortel, M.; Weiss, E.; Baty, D. Therapeutic Antibodies: Successes, Limitations and Hopes for the Future Br. J. Pharmacol. 2009, 157, 220-233 10.1111/j.1476-5381.2009.00190.x
14. Lobo, E. D.; Hansen, R. J.; Balthasar, J. P. Antibody Pharmacokinetics and Pharmacodynamics J. Pharm. Sci. 2004, 93, 2645-2668 10.1002/jps.20178
15. Holliger, P.; Hudson, P. J. Engineered Antibody Fragments and the Rise of Single Domains Nat. Biotechnol. 2005, 23, 1126-1136 10.1038/nbt1142
16. Todorovska, A.; Roovers, R. C.; Dolezal, O.; Kortt, A. A.; Hoogenboom, H. R.; Hudson, P. J. Design and Application of Diabodies, Triabodies and Tetrabodies for Cancer Targeting J. Immunol. Methods 2001, 248, 47-66 10.1016/S0022-1759(00)00342-2
17. Covell, D. G.; Barbet, J.; Holton, O. D.; Black, C. D.; Parker, R. J.; Weinstein, J. N. Pharmacokinetics of Monoclonal Immunoglobulin G1, F(Ab′)2, and Fab' in Mice Cancer Res. 1986, 46, 3969-3978
18. Thurber, G. M.; Schmidt, M. M.; Wittrup, K. D. Antibody Tumor Penetration: Transport Opposed by Systemic and Antigen-Mediated Clearance Adv. Drug Delivery Rev. 2008, 60, 1421-1434 10.1016/j.addr.2008.04.012
19. Massuger, L. F.; Claessens, R. A.; Pak, K. Y.; Boerman, O. C.; Daddona, P. E.; Koenders, E. B.; Kenemans, P.; Corstens, F. H. Tissue Distribution of 99mtc, 111in and 123i-Ov-Tl 3 Fab' in Ovarian Carcinoma Bearing Nude Mice Int. J. Rad. Appl. Instrum. B 1991, 18, 77-83 10.1016/0883-2897(91)90051-L
20. Muller, D.; Karle, A.; Meissburger, B.; Hofig, I.; Stork, R.; Kontermann, R. E. Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin J. Biol. Chem. 2007, 282, 12650-12660 10.1074/jbc.M700820200
21. Lipman, N. S.; Jackson, L. R.; Trudel, L. J.; Weis-Garcia, F. Monoclonal Versus Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information Resources ILAR J. 2005, 46, 258-268 10.1093/ilar.46.3.258
22. Goldenberg, D. M.; Chatal, J. F.; Barbet, J.; Boerman, O.; Sharkey, R. M. Cancer Imaging and Therapy with Bispecific Antibody Pretargeting Update Cancer Ther. 2007, 2, 19-31 10.1016/j.uct.2007.04.003
23. Tsurushita, N.; Hinton, P. R.; Kumar, S. Design of Humanized Antibodies: From Anti-Tac to Zenapax Methods 2005, 36, 69-83 10.1016/j.ymeth.2005.01.007
24. Presta, L. G. Engineering of Therapeutic Antibodies to Minimize Immunogenicity and Optimize Function Adv. Drug Delivery Rev. 2006, 58, 640-656 10.1016/j.addr.2006.01.026
25. Rouet, R.; Lowe, D.; Christ, D. Stability Engineering of the Human Antibody Repertoire FEBS Lett. 2014, 588, 269-277 10.1016/j.febslet.2013.11.029
26. Wu, A. M. Engineered Antibodies for Molecular Imaging of Cancer Methods 2014, 65, 139-147 10.1016/j.ymeth.2013.09.015
27. Adams, G. P.; Weiner, L. M. Monoclonal Antibody Therapy of Cancer Nat. Biotechnol. 2005, 23, 1147-1157 10.1038/nbt1137
28. Khalil, M. M.; Tremoleda, J. L.; Bayomy, T. B.; Gsell, W. Molecular Spect Imaging: An Overview Int. J. Mol. Imaging 2011, 2011, 796025 10.1155/2011/796025
29. Chen, K.; Chen, X. Design and Development of Molecular Imaging Probes Curr. Top. Med. Chem. 2010, 10, 1227-1236 10.2174/156802610791384225
30. Wang, A. Z.; Farokhzad, O. C. Current Progress of Aptamer-Based Molecular Imaging J. Nucl. Med. 2014, 55, 353-356 10.2967/jnumed.113.126144
31. Mattes, M. J. Radionuclide-Antibody Conjugates for Single-Cell Cytotoxicity Cancer 2002, 94, 1215-1223 10.1002/cncr.10288
32. Lawrence, S. Billion Dollar Babies-Biotech Drugs as Blockbusters Nat. Biotechnol. 2007, 25, 380-382 10.1038/nbt0407-380
33. Huang, Z. Q.; Buchsbaum, D. J. Monoclonal Antibodies in the Treatment of Pancreatic Cancer Immunotherapy 2009, 1, 223-229 10.2217/1750743X.1.2.223
34. Kalofonos, H. P.; Grivas, P. D. Monoclonal Antibodies in the Management of Solid Tumors Curr. Top. Med. Chem. 2006, 6, 1687-1705 10.2174/156802606778194208
35. Tian, J.; Cong, W.; Bai, J.; Jiang, M.; Liang, W. Recent Advances in Molecular Imaging Int. J. Biomed. Imaging 2007, 2007, 73198 10.1155/2007/73198
36. James, M. L.; Gambhir, S. S. A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications Physiol. Rev. 2012, 92, 897-965 10.1152/physrev.00049.2010
37. Chen, Z. Y.; Wang, Y. X.; Lin, Y.; Zhang, J. S.; Yang, F.; Zhou, Q. L.; Liao, Y. Y. Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy BioMed Res. Int. 2014, 2014, 819324 10.1155/2014/819324
38. Cinar, P.; Tempero, M. A. Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer Cancer J. 2012, 18, 653-664 10.1097/PPO.0b013e3182758985
39. Heskamp, S.; Hobo, W.; Molkenboer-Kuenen, J. D.; Olive, D.; Oyen, W. J.; Dolstra, H.; Boerman, O. C. Noninvasive Imaging of Tumor Pd-L1 Expression Using Radiolabeled Anti-Pd-L1 Antibodies Cancer Res. 2015, 75, 2928-2936 10.1158/0008-5472.CAN-14-3477
40. Konkalmatt, P. R.; Deng, D.; Thomas, S.; Wu, M. T.; Logsdon, C. D.; French, B. A.; Kelly, K. A. Plectin-1 Targeted Aav Vector for the Molecular Imaging of Pancreatic Cancer Front. Oncol. 2013, 3, 84 10.3389/fonc.2013.00084
41. Garrido-Laguna, I.; Hidalgo, M. Pancreatic Cancer: From State-of-the-Art Treatments to Promising Novel Therapies Nat. Rev. Clin. Oncol. 2015, 12, 319-334 10.1038/nrclinonc.2015.53
42. Pichler, B. J.; Wehrl, H. F.; Judenhofer, M. S. Latest Advances in Molecular Imaging Instrumentation J. Nucl. Med. 2008, 49 (Suppl. 2) 5S-23S 10.2967/jnumed.108.045880
43. Gambhir, S. S. Molecular Imaging of Cancer with Positron Emission Tomography Nat. Rev. Cancer 2002, 2, 683-693 10.1038/nrc882
44. Stockhofe, K.; Postema, J. M.; Schieferstein, H.; Ross, T. L. Radiolabeling of Nanoparticles and Polymers for Pet Imaging Pharmaceuticals 2014, 7, 392-418 10.3390/ph7040392
45. Hubalewska-Dydejczyk, A.; Sowa-Staszczak, A.; Tomaszuk, M.; Stefanska, A. Glp-1 and Exendin-4 for Imaging Endocrine Pancreas. A Review. Labelled Glucagon-Like Peptide-1 Analogues: Past, Present and Future Q. J. Nucl. Med. Mol. Imaging 2015, 59, 152-160
46. Sugyo, A.; Tsuji, A. B.; Sudo, H.; Nagatsu, K.; Koizumi, M.; Ukai, Y.; Kurosawa, G.; Zhang, M. R.; Kurosawa, Y.; Saga, T. Preclinical Evaluation of (8)(9)Zr-Labeled Human Antitransferrin Receptor Monoclonal Antibody as a Pet Probe Using a Pancreatic Cancer Mouse Model Nucl. Med. Commun. 2015, 36, 286-294 10.1097/MNM.0000000000000245
47. Kubo, S.; Yamamoto, K.; Magata, Y.; Iwasaki, Y.; Tamaki, N.; Yonekura, Y.; Konishi, J. Assessment of Pancreatic Blood Flow with Positron Emission Tomography and Oxygen-15 Water Ann. Nucl. Med. 1991, 5, 133-138 10.1007/BF03164627
48. Zhao, C.; Chen, Z.; Ye, X.; Zhang, Y.; Zhan, H.; Aburano, T.; Tian, M.; Zhang, H. Imaging a Pancreatic Carcinoma Xenograft Model with 11c-Acetate: A Comparison Study with 18f-Fdg Nucl. Med. Commun. 2009, 30, 971-977 10.1097/MNM.0b013e328330adfc
49. Wang, H.; Li, D.; Liu, S.; Liu, R.; Yuan, H.; Krasnoperov, V.; Shan, H.; Conti, P. S.; Gill, P. S.; Li, Z. Small-Animal Pet Imaging of Pancreatic Cancer Xenografts Using a 64cu-Labeled Monoclonal Antibody, Mab159 J. Nucl. Med. 2015, 56, 908-913 10.2967/jnumed.115.155812
50. Zhe-Yu, N.; Qiao-Fei, L.; Meng-Yi, W.; Li, Z.; Lu-Tian, Y.; Quan, L.; Yu-Pei, Z. Changes in the Expression of Glucose-Regulated Protein 78 in the Occurrence and Progression of Pancreatic Cancer in Mouse Models Zhongguo Yixue Kexueyuan Xuebao 2015, 37, 259-263 10.3881/j.issn.1000-503X.2015.03.002
51. Kobayashi, K.; Sasaki, T.; Takenaka, F.; Yakushiji, H.; Fujii, Y.; Kishi, Y.; Kita, S.; Shen, L.; Kumon, H.; Matsuura, E. A Novel Pet Imaging Using (6)(4)Cu-Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells J. Immunol. Res. 2015, 2015, 268172 10.1155/2015/268172
52. Zhang, Y.; Hong, H.; Cai, W. Pet Tracers Based on Zirconium-89 Curr. Radiopharm. 2011, 4, 131-139 10.2174/1874471011104020131
53. Sugyo, A.; Tsuji, A. B.; Sudo, H.; Nagatsu, K.; Koizumi, M.; Ukai, Y.; Kurosawa, G.; Zhang, M. R.; Kurosawa, Y.; Saga, T. Evaluation of (89)Zr-Labeled Human Anti-Cd147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer PLoS One 2013, 8, e61230 10.1371/journal.pone.0061230
54. Zhang, W.; Erkan, M.; Abiatari, I.; Giese, N. A.; Felix, K.; Kayed, H.; Buchler, M. W.; Friess, H.; Kleeff, J. Expression of Extracellular Matrix Metalloproteinase Inducer (Emmprin/Cd147) in Pancreatic Neoplasm and Pancreatic Stellate Cells Cancer Biol. Ther. 2007, 6, 218-227 10.4161/cbt.6.2.3623
55. Xiong, L.; Edwards, C. K., 3rd; Zhou, L. The Biological Function and Clinical Utilization of Cd147 in Human Diseases: A Review of the Current Scientific Literature Int. J. Mol. Sci. 2014, 15, 17411-17441 10.3390/ijms151017411
56. Chan, C. E.; Chan, A. H.; Hanson, B. J.; Ooi, E. E. The Use of Antibodies in the Treatment of Infectious Diseases Singapore Med. J. 2009, 50, 663-672 quiz 673
57. Weiner, L. M.; Surana, R.; Wang, S. Monoclonal Antibodies: Versatile Platforms for Cancer Immunotherapy Nat. Rev. Immunol. 2010, 10, 317-327 10.1038/nri2744
58. Chan, A. C.; Carter, P. J. Therapeutic Antibodies for Autoimmunity and Inflammation Nat. Rev. Immunol. 2010, 10, 301-316 10.1038/nri2761
59. Beck, A.; Wurch, T.; Bailly, C.; Corvaia, N. Strategies and Challenges for the Next Generation of Therapeutic Antibodies Nat. Rev. Immunol. 2010, 10, 345-352 10.1038/nri2747
60. Boyle, A. J.; Cao, P. J.; Hedley, D. W.; Sidhu, S. S.; Winnik, M. A.; Reilly, R. M. Micropet/Ct Imaging of Patient-Derived Pancreatic Cancer Xenografts Implanted Subcutaneously or Orthotopically in Nod-Scid Mice Using (64)Cu-Nota-Panitumumab F(Ab′)2 Fragments Nucl. Med. Biol. 2015, 42, 71-77 10.1016/j.nucmedbio.2014.10.009
61. Ozaki, N.; Ohmuraya, M.; Ida, S.; Hashimoto, D.; Ikuta, Y.; Chikamoto, A.; Hirota, M.; Baba, H. Serine Protease Inhibitor Kazal Type 1 and Epidermal Growth Factor Receptor Are Expressed in Pancreatic Tubular Adenocarcinoma, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Intraepithelial Neoplasia J. Hepatobiliary Pancreat. Sci. 2013, 20, 620-627 10.1007/s00534-012-0587-6
62. Viola-Villegas, N. T.; Rice, S. L.; Carlin, S.; Wu, X.; Evans, M. J.; Sevak, K. K.; Drobjnak, M.; Ragupathi, G.; Sawada, R.; Scholz, W. W.; Livingston, P. O.; Lewis, J. S. Applying Pet to Broaden the Diagnostic Utility of the Clinically Validated Ca19.9 Serum Biomarker for Oncology J. Nucl. Med. 2013, 54, 1876-1882 10.2967/jnumed.113.119867
63. Sawada, R.; Sun, S. M.; Wu, X.; Hong, F.; Ragupathi, G.; Livingston, P. O.; Scholz, W. W. Human Monoclonal Antibodies to Sialyl-Lewis (Ca19.9) with Potent Cdc, Adcc, and Antitumor Activity Clin. Cancer Res. 2011, 17, 1024-1032 10.1158/1078-0432.CCR-10-2640
64. Girgis, M. D.; Kenanova, V.; Olafsen, T.; McCabe, K. E.; Wu, A. M.; Tomlinson, J. S. Anti-Ca19-9 Diabody as a Pet Imaging Probe for Pancreas Cancer J. Surg. Res. 2011, 170, 169-178 10.1016/j.jss.2011.03.065
65. Shi, C.; Merchant, N.; Newsome, G.; Goldenberg, D. M.; Gold, D. V. Differentiation of Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis by Pam4 Immunohistochemistry Arch. Pathol. Lab. Med. 2014, 138, 220-228 10.5858/arpa.2013-0056-OA
66. Hong, H.; Zhang, Y.; Nayak, T. R.; Engle, J. W.; Wong, H. C.; Liu, B.; Barnhart, T. E.; Cai, W. Immuno-Pet of Tissue Factor in Pancreatic Cancer J. Nucl. Med. 2012, 53, 1748-1754 10.2967/jnumed.112.105460
67. Kasthuri, R. S.; Taubman, M. B.; Mackman, N. Role of Tissue Factor in Cancer J. Clin. Oncol. 2009, 27, 4834-4838 10.1200/JCO.2009.22.6324
68. Khorana, A. A.; Ahrendt, S. A.; Ryan, C. K.; Francis, C. W.; Hruban, R. H.; Hu, Y. C.; Hostetter, G.; Harvey, J.; Taubman, M. B. Tissue Factor Expression, Angiogenesis, and Thrombosis in Pancreatic Cancer Clin. Cancer Res. 2007, 13, 2870-2875 10.1158/1078-0432.CCR-06-2351
69. Scholzel, S.; Zimmermann, W.; Schwarzkopf, G.; Grunert, F.; Rogaczewski, B.; Thompson, J. Carcinoembryonic Antigen Family Members Ceacam6 and Ceacam7 Are Differentially Expressed in Normal Tissues and Oppositely Deregulated in Hyperplastic Colorectal Polyps and Early Adenomas Am. J. Pathol. 2000, 156, 595-605 10.1016/S0002-9440(10)64764-5
70. Blumenthal, R. D.; Leon, E.; Hansen, H. J.; Goldenberg, D. M. Expression Patterns of Ceacam5 and Ceacam6 in Primary and Metastatic Cancers BMC Cancer 2007, 7, 2 10.1186/1471-2407-7-2
71. Duxbury, M. S.; Ito, H.; Zinner, M. J.; Ashley, S. W.; Whang, E. E. Ceacam6 Gene Silencing Impairs Anoikis Resistance and in Vivo Metastatic Ability of Pancreatic Adenocarcinoma Cells Oncogene 2004, 23, 465-473 10.1038/sj.onc.1207036
72. Duxbury, M. S.; Ito, H.; Benoit, E.; Waseem, T.; Ashley, S. W.; Whang, E. E. A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells Cancer Res. 2004, 64, 3987-3993 10.1158/0008-5472.CAN-04-0424
73. Niu, G.; Murad, Y. M.; Gao, H.; Hu, S.; Guo, N.; Jacobson, O.; Nguyen, T. D.; Zhang, J.; Chen, X. Molecular Targeting of Ceacam6 Using Antibody Probes of Different Sizes J. Controlled Release 2012, 161, 18-24 10.1016/j.jconrel.2012.04.043
74. Girgis, M. D.; Olafsen, T.; Kenanova, V.; McCabe, K. E.; Wu, A. M.; Tomlinson, J. S. Targeting Cea in Pancreas Cancer Xenografts with a Mutated Scfv-Fc Antibody Fragment EJNMMI Res. 2011, 1, 24 10.1186/2191-219X-1-24
75. de Jong, M.; Essers, J.; van Weerden, W. M. Imaging Preclinical Tumour Models: Improving Translational Power Nat. Rev. Cancer 2014, 14, 481-493 10.1038/nrc3751
76. DePuey, E. G. Advances in Spect Camera Software and Hardware: Currently Available and New on the Horizon J. Nucl. Cardiol. 2012, 19, 551-581 quiz 585 10.1007/s12350-012-9544-7
77. Hicks, R. J.; Hofman, M. S. Is There Still a Role for SPECT-CT in Oncology in the PET-CT Era? Nat. Rev. Clin. Oncol. 2012, 9, 712-720 10.1038/nrclinonc.2012.188
78. Hnatowich, D. J. Recent Developments in the Radiolabeling of Antibodies with Iodine, Indium, and Technetium Semin. Nucl. Med. 1990, 20, 80-91 10.1016/S0001-2998(05)80178-3
79. Moffat, F. L., Jr.; Pinsky, C. M.; Hammershaimb, L.; Petrelli, N. J.; Patt, Y. Z.; Whaley, F. S.; Goldenberg, D. M. Clinical Utility of External Immunoscintigraphy with the Immu-4 Technetium-99m Fab' Antibody Fragment in Patients Undergoing Surgery for Carcinoma of the Colon and Rectum: Results of a Pivotal, Phase III Trial. The Immunomedics Study Group J. Clin. Oncol. 1996, 14, 2295-2305
80. Ha, L.; Mansberg, R.; Nguyen, D.; Bui, C. Increased Activity on in-111 Octreotide Imaging Due to Radiation Fibrosis Clin. Nucl. Med. 2008, 33, 46-48 10.1097/RLU.0b013e31815c5073
81. Pillai, M. R.; Dash, A.; Knapp, F. F., Jr. Sustained Availability of 99mtc: Possible Paths Forward J. Nucl. Med. 2013, 54, 313-323 10.2967/jnumed.112.110338
82. Chen, C. L.; Wang, Y.; Lee, J. J.; Tsui, B. M. Toward Quantitative Small Animal Pinhole Spect: Assessment of Quantitation Accuracy Prior to Image Compensations Mol. Imaging Biol. 2009, 11, 195-203 10.1007/s11307-008-0181-0
83. Hwang, A. B.; Franc, B. L.; Gullberg, G. T.; Hasegawa, B. H. Assessment of the Sources of Error Affecting the Quantitative Accuracy of Spect Imaging in Small Animals Phys. Med. Biol. 2008, 53, 2233-2252 10.1088/0031-9155/53/9/002
84. Von Schulthess, G. K.; Hany, T. F. Imaging and Pet-Pet/Ct Imaging J. Radiol. 2008, 89, 438-447 quiz 448 10.1016/S0221-0363(08)89019-1
85. Lee, J. S.; Kim, J. H. Recent Advances in Hybrid Molecular Imaging Systems Semin Musculoskelet Radiol. 2014, 18, 103-122 10.1055/s-0034-1371014
86. Koba, W.; Jelicks, L. A.; Fine, E. J. Micropet/Spect/Ct Imaging of Small Animal Models of Disease Am. J. Pathol. 2013, 182, 319-324 10.1016/j.ajpath.2012.09.025
87. Lindenberg, L.; Thomas, A.; Adler, S.; Mena, E.; Kurdziel, K.; Maltzman, J.; Wallin, B.; Hoffman, K.; Pastan, I.; Paik, C. H.; Choyke, P.; Hassan, R. Safety and Biodistribution of 111in-Amatuximab in Patients with Mesothelin Expressing Cancers Using Single Photon Emission Computed Tomography-Computed Tomography (Spect-Ct) Imaging Oncotarget. 2015, 6, 4496-4504 10.18632/oncotarget.2883
88. Leconet, W.; Larbouret, C.; Chardes, T.; Thomas, G.; Neiveyans, M.; Busson, M.; Jarlier, M.; Radosevic-Robin, N.; Pugniere, M.; Bernex, F.; Penault-Llorca, F.; Pasquet, J. M.; Pelegrin, A.; Robert, B. Preclinical Validation of Axl Receptor as a Target for Antibody-Based Pancreatic Cancer Immunotherapy Oncogene 2014, 33, 5405-5414 10.1038/onc.2013.487
89. Song, X.; Wang, H.; Logsdon, C. D.; Rashid, A.; Fleming, J. B.; Abbruzzese, J. L.; Gomez, H. F.; Evans, D. B.; Wang, H. Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma Cancer 2011, 117, 734-743 10.1002/cncr.25483
90. Sabbah, E. N.; Kadouche, J.; Ellison, D.; Finucane, C.; Decaudin, D.; Mather, S. J. In Vitro and in Vivo Comparison of DTPA- and DOTA-Conjugated Antiferritin Monoclonal Antibody for Imaging and Therapy of Pancreatic Cancer Nucl. Med. Biol. 2007, 34, 293-304 10.1016/j.nucmedbio.2007.01.004
91. Sawada, T.; Nishihara, T.; Yamamoto, A.; Teraoka, H.; Yamashita, Y.; Okamura, T.; Ochi, H.; Ho, J. J.; Kim, Y. S.; Hirakawa, K. Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by 111 in-Labeled Chimeric Monoclonal Antibody Nd2 Jpn. J. Cancer Res. 1999, 90, 1179-1186 10.1111/j.1349-7006.1999.tb00693.x
92. Kufe, D. W. Mucins in Cancer: Function, Prognosis and Therapy Nat. Rev. Cancer 2009, 9, 874-885 10.1038/nrc2761
93. Kaur, S.; Kumar, S.; Momi, N.; Sasson, A. R.; Batra, S. K. Mucins in Pancreatic Cancer and Its Microenvironment Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 607-620 10.1038/nrgastro.2013.120
94. Foss, C. A.; Fox, J. J.; Feldmann, G.; Maitra, A.; Iacobuzio-Donohue, C.; Kern, S. E.; Hruban, R.; Pomper, M. G. Radiolabeled Anti-Claudin 4 and Anti-Prostate Stem Cell Antigen: Initial Imaging in Experimental Models of Pancreatic Cancer Mol. Imaging 2007, 6, 131-139
95. Michl, P.; Buchholz, M.; Rolke, M.; Kunsch, S.; Lohr, M.; McClane, B.; Tsukita, S.; Leder, G.; Adler, G.; Gress, T. M. Claudin-4: A New Target for Pancreatic Cancer Treatment Using Clostridium Perfringens Enterotoxin Gastroenterology 2001, 121, 678-684 10.1053/gast.2001.27124
96. Nichols, L. S.; Ashfaq, R.; Iacobuzio-Donahue, C. A. Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer: Support for Use as a Therapeutic Target Am. J. Clin. Pathol. 2004, 121, 226-230 10.1309/K144PHVDDUPDD401
97. Leung, K., 111In-P-Benzyl Isothiocyanate-1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-14C5 Monoclonal Antibody. In Molecular Imaging and Contrast Agent Database (MICAD); Bethesda, MD, 2004.
98. Vervoort, L.; Burvenich, I.; Staelens, S.; Dumolyn, C.; Waegemans, E.; Van Steenkiste, M.; Baird, S. K.; Scott, A. M.; De Vos, F. Preclinical Evaluation of Monoclonal Antibody 14c5 for Targeting Pancreatic Cancer Cancer Biother.Radiopharm. 2010, 25, 193-205 10.1089/cbr.2009.0696
99. Erickson, J. J. Development of the Scintillation Camera Am. J. Physiol. Imaging 1992, 7, 98-104
100. Stefanovic, L. [The Beginnings and Development of Diagnostic Imaging in Nuclear Medicine] Med. Pregl. 2001, 54, 289-296
101. Kaufmann, L. W.; Vaillant, J. C.; van Gulik, T. M.; van Royen, E. A.; Parc, R.; Obertop, H. Efficacy of Monoclonal Antibody 131i-B72.3 Immunoscintigraphy of Pancreatic Adenocarcinoma Xenografts in Nude Mice Eur. J. Surg. 1999, 165, 659-664 10.1080/11024159950189717
102. Otsuji, E.; Yamaguchi, T.; Yamaoka, N.; Kato, M.; Kotani, T.; Kitamura, K.; Yamaguchi, N.; Takahashi, T. Enhanced Tumor Localization of Radiolabeled Fab Fragments of Monoclonal Antibody A7 in Nude Mice Bearing Human Pancreatic Carcinoma Xenografts Jpn. J. Cancer Res. 1993, 84, 914-920 10.1111/j.1349-7006.1993.tb02066.x
103. Otsuji, E.; Matsumura, H.; Okamoto, K.; Toma, A.; Kuriu, Y.; Ichikawa, D.; Hagiwara, A.; Yamagishi, H. Application of 99mtc Labeled Chimeric Fab Fragments of Monoclonal Antibody A7 for Immunoscintigraphy of Pancreatic Carcinoma J. Surg. Oncol. 2003, 84, 160-165 10.1002/jso.10311
104. Scherzinger, A. L.; Hendee, W. R. Basic Principles of Magnetic Resonance Imaging - an Update West. J. Med. 1985, 143, 782-792
105. Plewes, D. B.; Kucharczyk, W. Physics of Mri: A Primer J. Magn. Reson. Imaging. 2012, 35, 1038-1054 10.1002/jmri.23642
106. Jasanoff, A. Mri Contrast Agents for Functional Molecular Imaging of Brain Activity Curr. Opin. Neurobiol. 2007, 17, 593-600 10.1016/j.conb.2007.11.002
107. Kartalis, N.; Mucelli, R. M.; Sundin, A. Recent Developments in Imaging of Pancreatic Neuroendocrine Tumors Ann. Gastroenterol. 2015, 28, 193-202
108. Kalra, M. K.; Maher, M. M.; Mueller, P. R.; Saini, S. State-of-the-Art Imaging of Pancreatic Neoplasms Br. J. Radiol. 2003, 76, 857-865 10.1259/bjr/16642775
109. Raman, S. P.; Horton, K. M.; Fishman, E. K. Multimodality Imaging of Pancreatic Cancer-Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography Cancer J. 2012, 18, 511-522 10.1097/PPO.0b013e318274a461
110. Grimm, J.; Potthast, A.; Wunder, A.; Moore, A. Magnetic Resonance Imaging of the Pancreas and Pancreatic Tumors in a Mouse Orthotopic Model of Human Cancer Int. J. Cancer 2003, 106, 806-811 10.1002/ijc.11281
111. Deng, L.; Ke, X.; He, Z.; Yang, D.; Gong, H.; Zhang, Y.; Jing, X.; Yao, J.; Chen, J. A Msln-Targeted Multifunctional Nanoimmunoliposome for Mri and Targeting Therapy in Pancreatic Cancer Int. J. Nanomed. 2012, 7, 5053-5065 10.2147/IJN.S34801
112. Yoon, H. Y.; Saravanakumar, G.; Heo, R.; Choi, S. H.; Song, I. C.; Han, M. H.; Kim, K.; Park, J. H.; Choi, K.; Kwon, I. C.; Park, K. Hydrotropic Magnetic Micelles for Combined Magnetic Resonance Imaging and Cancer Therapy J. Controlled Release 2012, 160, 692-698 10.1016/j.jconrel.2012.04.012
113. Lim, E. K.; Kim, T.; Paik, S.; Haam, S.; Huh, Y. M.; Lee, K. Nanomaterials for Theranostics: Recent Advances and Future Challenges Chem. Rev. 2015, 115, 327-394 10.1021/cr300213b
114. Wang, X.; Xing, X.; Zhang, B.; Liu, F.; Cheng, Y.; Shi, D. Surface Engineered Antifouling Optomagnetic Spions for Bimodal Targeted Imaging of Pancreatic Cancer Cells Int. J. Nanomed. 2014, 9, 1601-1615 10.2147/IJN.S58334
115. Fei, L. M.; Wang, C. L.; Zhao, W. H.; Cui, K.; Zhang, B.; Zhou, W. Y.; Zhong, W. X.; Li, S. [Quantitative Analysis and Significance of CXCL12 and CXCR4 Expression with Lymphangiogenesis of Pancreatic Adenocarcinoma] Zhonghua Waike Zazhi 2009, 47, 783-786
116. Mori, T.; Doi, R.; Koizumi, M.; Toyoda, E.; Ito, D.; Kami, K.; Masui, T.; Fujimoto, K.; Tamamura, H.; Hiramatsu, K.; Fujii, N.; Imamura, M. CXCR4 Antagonist Inhibits Stromal Cell-Derived Factor 1-Induced Migration and Invasion of Human Pancreatic Cancer Mol. Cancer Ther. 2004, 3, 29-37
117. Marchesi, F.; Monti, P.; Leone, B. E.; Zerbi, A.; Vecchi, A.; Piemonti, L.; Mantovani, A.; Allavena, P. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional Cxcr4 Cancer Res. 2004, 64, 8420-8427 10.1158/0008-5472.CAN-04-1343
118. He, Y.; Song, W.; Lei, J.; Li, Z.; Cao, J.; Huang, S.; Meng, J.; Xu, H.; Jin, Z.; Xue, H. Anti-Cxcr4Monoclonal Antibody Conjugated to Ultrasmall Superparamagnetic Iron Oxide Nanoparticles in an Application of Mr Molecular Imaging of Pancreatic Cancer Cell Lines Acta Radiol. 2012, 53, 1049-1058 10.1258/ar.2012.120055
119. Thomas, R. M.; Kim, J.; Revelo-Penafiel, M. P.; Angel, R.; Dawson, D. W.; Lowy, A. M. The Chemokine Receptor Cxcr4 Is Expressed in Pancreatic Intraepithelial Neoplasia Gut 2008, 57, 1555-1560 10.1136/gut.2007.143941
120. Yang, L.; Mao, H.; Wang, Y. A.; Cao, Z.; Peng, X.; Wang, X.; Duan, H.; Ni, C.; Yuan, Q.; Adams, G.; Smith, M. Q.; Wood, W. C.; Gao, X.; Nie, S. Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging Small 2009, 5, 235-243 10.1002/smll.200800714
121. Xie, D.; Xie, K. Pancreatic Cancer Stromal Biology and Therapy Genes Dis. 2015, 2, 133-143 10.1016/j.gendis.2015.01.002
122. Pirollo, K. F.; Dagata, J.; Wang, P.; Freedman, M.; Vladar, A.; Fricke, S.; Ileva, L.; Zhou, Q.; Chang, E. H. A Tumor-Targeted Nanodelivery System to Improve Early Mri Detection of Cancer Mol. Imaging 2006, 5, 41-52
123. Chen, W.; Ayala-Orozco, C.; Biswal, N. C.; Perez-Torres, C.; Bartels, M.; Bardhan, R.; Stinnet, G.; Liu, X. D.; Ji, B.; Deorukhkar, A.; Brown, L. V.; Guha, S.; Pautler, R. G.; Krishnan, S.; Halas, N. J.; Joshi, A. Targeting Pancreatic Cancer with Magneto-Fluorescent Theranostic Gold Nanoshells Nanomedicine (London, U. K.) 2014, 9, 1209-1222 10.2217/nnm.13.84
124. Moniaux, N.; Chakraborty, S.; Yalniz, M.; Gonzalez, J.; Shostrom, V. K.; Standop, J.; Lele, S. M.; Ouellette, M.; Pour, P. M.; Sasson, A. R.; Brand, R. E.; Hollingsworth, M. A.; Jain, M.; Batra, S. K. Early Diagnosis of Pancreatic Cancer: Neutrophil Gelatinase-Associated Lipocalin as a Marker of Pancreatic Intraepithelial Neoplasia Br. J. Cancer 2008, 98, 1540-1547 10.1038/sj.bjc.6604329
125. Kherlopian, A. R.; Song, T.; Duan, Q.; Neimark, M. A.; Po, M. J.; Gohagan, J. K.; Laine, A. F. A Review of Imaging Techniques for Systems Biology BMC Syst. Biol. 2008, 2, 74 10.1186/1752-0509-2-74
126. Balas, C. Review of Biomedical Optical Imaging-a Powerful, Non-Invasive, Non-Ionizing Technology for Improving in Vivo Diagnosis Meas. Sci. Technol. 2009, 20, 104020 10.1088/0957-0233/20/10/104020
127. Robinson, J. T.; Hong, G.; Liang, Y.; Zhang, B.; Yaghi, O. K.; Dai, H. In Vivo Fluorescence Imaging in the Second near-Infrared Window with Long Circulating Carbon Nanotubes Capable of Ultrahigh Tumor Uptake J. Am. Chem. Soc. 2012, 134, 10664-10669 10.1021/ja303737a
128. Smith, A. M.; Mancini, M. C.; Nie, S. Bioimaging: Second Window for in Vivo Imaging Nat. Nanotechnol. 2009, 4, 710-711 10.1038/nnano.2009.326
129. Patel, A. R.; Lim, E.; Francis, K. P.; Singh, M. Opening up the Optical Imaging Window Using Nano-Luciferin Pharm. Res. 2014, 31, 3073-3084 10.1007/s11095-014-1400-9
130. Pansare, V.; Hejazi, S.; Faenza, W.; Prud'homme, R. K. Review of Long-Wavelength Optical and Nir Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers Chem. Mater. 2012, 24, 812-827 10.1021/cm2028367
131. Tran Cao, H. S.; Kaushal, S.; Metildi, C. A.; Menen, R. S.; Lee, C.; Snyder, C. S.; Messer, K.; Pu, M.; Luiken, G. A.; Talamini, M. A.; Hoffman, R. M.; Bouvet, M. Tumor-Specific Fluorescence Antibody Imaging Enables Accurate Staging Laparoscopy in an Orthotopic Model of Pancreatic Cancer Hepato-Gastroenterology 2012, 59, 1994-1999 10.5754/hge11836
132. Kaushal, S.; McElroy, M. K.; Luiken, G. A.; Talamini, M. A.; Moossa, A. R.; Hoffman, R. M.; Bouvet, M. Fluorophore-Conjugated Anti-Cea Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer J. Gastrointest. Surg. 2008, 12, 1938-1950 10.1007/s11605-008-0581-0
133. Tran Cao, H. S.; Kaushal, S.; Lee, C.; Snyder, C. S.; Thompson, K. J.; Horgan, S.; Talamini, M. A.; Hoffman, R. M.; Bouvet, M. Fluorescence Laparoscopy Imaging of Pancreatic Tumor Progression in an Orthotopic Mouse Model Surg. Endosc. 2011, 25, 48-54 10.1007/s00464-010-1127-6
134. Boonstra, M. C.; Tolner, B.; Schaafsma, B. E.; Boogerd, L. S.; Prevoo, H. A.; Bhavsar, G.; Kuppen, P. J.; Sier, C. F.; Bonsing, B. A.; Frangioni, J. V.; van de Velde, C. J.; Chester, K. A.; Vahrmeijer, A. L. Preclinical Evaluation of a Novel Cea-Targeting near-Infrared Fluorescent Tracer Delineating Colorectal and Pancreatic Tumors Int. J. Cancer 2015, 137, 1910-1920 10.1002/ijc.29571
135. Boehm, M. K.; Corper, A. L.; Wan, T.; Sohi, M. K.; Sutton, B. J.; Thornton, J. D.; Keep, P. A.; Chester, K. A.; Begent, R. H.; Perkins, S. J. Crystal Structure of the Anti-(Carcinoembryonic Antigen) Single-Chain Fv Antibody Mfe-23 and a Model for Antigen Binding Based on Intermolecular Contacts Biochem. J. 2000, 346 (Part 2) 519-528 10.1042/bj3460519
136. Hiroshima, Y.; Maawy, A.; Zhang, Y.; Murakami, T.; Momiyama, M.; Mori, R.; Matsuyama, R.; Chishima, T.; Tanaka, K.; Ichikawa, Y.; Endo, I.; Hoffman, R. M.; Bouvet, M. Fluorescence-Guided Surgery, but Not Bright-Light Surgery, Prevents Local Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (Pdox) Model Resistant to Neoadjuvant Chemotherapy (Nac) Pancreatology 2015, 15, 295-301 10.1016/j.pan.2015.02.008
137. Maawy, A. A.; Hiroshima, Y.; Zhang, Y.; Garcia-Guzman, M.; Luiken, G. A.; Kobayashi, H.; Hoffman, R. M.; Bouvet, M. Photoimmunotherapy Lowers Recurrence after Pancreatic Cancer Surgery in Orthotopic Nude Mouse Models J. Surg. Res. 2015, 197, 5-11 10.1016/j.jss.2015.02.037
138. Bouvet, M.; Hoffman, R. M. Fluorescence-Guided Surgery: It Is the Cure That Matters: In Reply to Giorgakis and Colleagues J. Am. Coll. Surg. 2015, 220, 377-379 10.1016/j.jamcollsurg.2014.12.002
139. Maawy, A. A.; Hiroshima, Y.; Zhang, Y.; Luiken, G. A.; Hoffman, R. M.; Bouvet, M. Specific Tumor Labeling Enhanced by Polyethylene Glycol Linkage of near Infrared Dyes Conjugated to a Chimeric Anti-Carcinoembryonic Antigen Antibody in a Nude Mouse Model of Human Pancreatic Cancer J. Biomed. Opt. 2014, 19, 101504 10.1117/1.JBO.19.10.101504
140. Metildi, C. A.; Kaushal, S.; Luiken, G. A.; Hoffman, R. M.; Bouvet, M. Advantages of Fluorescence-Guided Laparoscopic Surgery of Pancreatic Cancer Labeled with Fluorescent Anti-Carcinoembryonic Antigen Antibodies in an Orthotopic Mouse Model J. Am. Coll. Surg. 2014, 219, 132-141 10.1016/j.jamcollsurg.2014.02.021
141. Metildi, C. A.; Kaushal, S.; Lee, C.; Hardamon, C. R.; Snyder, C. S.; Luiken, G. A.; Talamini, M. A.; Hoffman, R. M.; Bouvet, M. An LED Light Source and Novel Fluorophore Combinations Improve Fluorescence Laparoscopic Detection of Metastatic Pancreatic Cancer in Orthotopic Mouse Models J. Am. Coll. Surg. 2012, 214, 997-1007 e1002 10.1016/j.jamcollsurg.2012.02.009
142. Wu, E.; Zhou, S.; Bhat, K.; Ma, Q. Ca 19-9 and Pancreatic Cancer Clin. Adv. Hematol. Oncol. 2013, 11, 53-55
143. Ballehaninna, U. K.; Chamberlain, R. S. Serum Ca 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review Indian J. Surg. Oncol. 2011, 2, 88-100 10.1007/s13193-011-0042-1
144. McElroy, M.; Kaushal, S.; Luiken, G. A.; Talamini, M. A.; Moossa, A. R.; Hoffman, R. M.; Bouvet, M. Imaging of Primary and Metastatic Pancreatic Cancer Using a Fluorophore-Conjugated Anti-Ca19-9 Antibody for Surgical Navigation World J. Surg. 2008, 32, 1057-1066 10.1007/s00268-007-9452-1
145. Hiroshima, Y.; Maawy, A.; Zhang, Y.; Murakami, T.; Momiyama, M.; Mori, R.; Matsuyama, R.; Katz, M. H.; Fleming, J. B.; Chishima, T.; Tanaka, K.; Ichikawa, Y.; Endo, I.; Hoffman, R. M.; Bouvet, M. Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (Pdox) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-Ca 19-9-Conjugated Fluorophore PLoS One 2014, 9, e114310 10.1371/journal.pone.0114310
146. Bunger, S.; Laubert, T.; Roblick, U. J.; Habermann, J. K. Serum Biomarkers for Improved Diagnostic of Pancreatic Cancer: A Current Overview J. Cancer Res. Clin. Oncol. 2011, 137, 375-389 10.1007/s00432-010-0965-x
147. Qu, C. F.; Li, Y.; Song, Y. J.; Rizvi, S. M.; Raja, C.; Zhang, D.; Samra, J.; Smith, R.; Perkins, A. C.; Apostolidis, C.; Allen, B. J. Muc1 Expression in Primary and Metastatic Pancreatic Cancer Cells for in Vitro Treatment by (213)Bi-C595 Radioimmunoconjugate Br. J. Cancer 2004, 91, 2086-2093 10.1038/sj.bjc.6602232
148. Bafna, S.; Kaur, S.; Batra, S. K. Membrane-Bound Mucins: The Mechanistic Basis for Alterations in the Growth and Survival of Cancer Cells Oncogene 2010, 29, 2893-2904 10.1038/onc.2010.87
149. Park, J. Y.; Hiroshima, Y.; Lee, J. Y.; Maawy, A. A.; Hoffman, R. M.; Bouvet, M. Muc1 Selectively Targets Human Pancreatic Cancer in Orthotopic Nude Mouse Models PLoS One 2015, 10, e0122100 10.1371/journal.pone.0122100
150. Kosaka, N.; McCann, T. E.; Mitsunaga, M.; Choyke, P. L.; Kobayashi, H. Real-Time Optical Imaging Using Quantum Dot and Related Nanocrystals Nanomedicine (London, U. K.) 2010, 5, 765-776 10.2217/nnm.10.49
151. Yong, K. T.; Ding, H.; Roy, I.; Law, W. C.; Bergey, E. J.; Maitra, A.; Prasad, P. N. Imaging Pancreatic Cancer Using Bioconjugated Inp Quantum Dots ACS Nano 2009, 3, 502-510 10.1021/nn8008933
152. Chen, N.; He, Y.; Su, Y.; Li, X.; Huang, Q.; Wang, H.; Zhang, X.; Tai, R.; Fan, C. The Cytotoxicity of Cadmium-Based Quantum Dots Biomaterials 2012, 33, 1238-1244 10.1016/j.biomaterials.2011.10.070
153. Kampmeier, F.; Niesen, J.; Koers, A.; Ribbert, M.; Brecht, A.; Fischer, R.; Kiessling, F.; Barth, S.; Thepen, T. Rapid Optical Imaging of Egf Receptor Expression with a Single-Chain Antibody Snap-Tag Fusion Protein Eur. J. Nucl. Med. Mol. Imaging 2010, 37, 1926-1934 10.1007/s00259-010-1482-5
154. Bowen, T. Radiation-Induced Thermoacoustic Soft-Tissue Imaging Ultrason. Symp. Proc. 1982, 29, 187-187 10.1109/ULTSYM.1981.197737
155. Fan, Y.; Mandelis, A.; Spirou, G.; Vitkin, I. A. Development of a Laser Photothermoacoustic Frequency-Swept System for Subsurface Imaging: Theory and Experiment J. Acoust. Soc. Am. 2004, 116, 3523-3533 10.1121/1.1819393
156. Lashkari, B.; Mandelis, A. Photoacoustic Radar Imaging Signal-to-Noise Ratio, Contrast, and Resolution Enhancement Using Nonlinear Chirp Modulation Opt. Lett. 2010, 35, 1623-1625 10.1364/OL.35.001623
157. Maslov, K.; Wang, L. V. Photoacoustic Imaging of Biological Tissue with Intensity-Modulated Continuous-Wave Laser J. Biomed. Opt. 2008, 13, 024006 10.1117/1.2904965
158. Dovlo, E.; Lashkari, B.; Mandelis, A.; Shi, W.; Liu, F. F. Photoacoustic Radar Phase-Filtered Spatial Resolution and Co-Registered Ultrasound Image Enhancement for Tumor Detection Biomed. Opt. Express 2015, 6, 1003-1009 10.1364/BOE.6.001003
159. Taruttis, A.; Ntziachristos, V. Advances in Real-Time Multispectral Optoacoustic Imaging and Its Applications Nat. Photonics 2015, 9, 219-227 10.1038/nphoton.2015.29
160. Wang, L. V.; Hu, S. Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs Science 2012, 335, 1458-1462 10.1126/science.1216210
161. Xia, J.; Yao, J.; Wang, L. V. Photoacoustic Tomography: Principles and Advances Electromagn Waves (Camb). 2014, 147, 1-22 10.2528/PIER14032303
162. Xia, J.; Wang, L. V. Small-Animal Whole-Body Photoacoustic Tomography: A Review IEEE Trans. Biomed. Eng. 2014, 61, 1380-1389 10.1109/TBME.2013.2283507
163. Beard, P. Interface Focus 2011, 1, 602-631 10.1098/rsfs.2011.0028
164. Nie, L.; Wang, S.; Wang, X.; Rong, P.; Ma, Y.; Liu, G.; Huang, P.; Lu, G.; Chen, X. In Vivo Volumetric Photoacoustic Molecular Angiography and Therapeutic Monitoring with Targeted Plasmonic Nanostars Small 2014, 10, 1585-1593 10.1002/smll.201302924
165. Kruger, R. A.; Lam, R. B.; Reinecke, D. R.; Del Rio, S. P.; Doyle, R. P. Photoacoustic Angiography of the Breast Med. Phys. 2010, 37, 6096-6100 10.1118/1.3497677
166. Wang, X.; Ku, G.; Wegiel, M. A.; Bornhop, D. J.; Stoica, G.; Wang, L. V. Noninvasive Photoacoustic Angiography of Animal Brains in Vivo with near-Infrared Light and an Optical Contrast Agent Opt. Lett. 2004, 29, 730-732 10.1364/OL.29.000730
167. Kim, C.; Favazza, C.; Wang, L. V. In Vivo Photoacoustic Tomography of Chemicals: High-Resolution Functional and Molecular Optical Imaging at New Depths Chem. Rev. 2010, 110, 2756-2782 10.1021/cr900266s
168. Lakshman, M.; Needles, A. Screening and Quantification of the Tumor Microenvironment with Micro-Ultrasound and Photoacoustic Imaging. Nat. Methods 2015, 12.
169. Homan, K. A.; Souza, M.; Truby, R.; Luke, G. P.; Green, C.; Vreeland, E.; Emelianov, S. Silver Nanoplate Contrast Agents for in Vivo Molecular Photoacoustic Imaging ACS Nano 2012, 6, 641-650 10.1021/nn204100n
170. Homan, K.; Shah, J.; Gomez, S.; Gensler, H.; Karpiouk, A.; Brannon-Peppas, L.; Emelianov, S. Combined Ultrasound and Photoacoustic Imaging of Pancreatic Cancer Using Nanocage Contrast Agents Proc. SPIE 2009, 7177, 71771M 10.1117/12.807520
171. Hudson, S. V.; Huang, J. S.; Yin, W.; Albeituni, S.; Rush, J.; Khanal, A.; Yan, J.; Ceresa, B. P.; Frieboes, H. B.; McNally, L. R. Targeted Noninvasive Imaging of Egfr-Expressing Orthotopic Pancreatic Cancer Using Multispectral Optoacoustic Tomography Cancer Res. 2014, 74, 6271-6279 10.1158/0008-5472.CAN-14-1656
172. Xu, J.; Cai, X.; Yao, J.; Dirk, S.; Zeng, C.; Hawkins, W. G.; Wang, L. V.; Mach, R. H. Abstract 356: Photoacoustic Imaging of Pancreatic Cancer Proliferation Via Sigma-2 Receptor/Pgrmc1-Eyfp Cancer Res. 2012, 72, 356-356 10.1158/1538-7445.AM2012-356
173. Junttila, M. R.; de Sauvage, F. J. Influence of Tumour Micro-Environment Heterogeneity on Therapeutic Response Nature 2013, 501, 346-354 10.1038/nature12626
174. Chen, F.; Nayak, T. R.; Goel, S.; Valdovinos, H. F.; Hong, H.; Theuer, C. P.; Barnhart, T. E.; Cai, W. In Vivo Tumor Vasculature Targeted Pet/Nirf Imaging with Trc105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles Mol. Pharmaceutics 2014, 11, 4007-4014 10.1021/mp500306k
175. Hong, H.; Severin, G. W.; Yang, Y.; Engle, J. W.; Zhang, Y.; Barnhart, T. E.; Liu, G.; Leigh, B. R.; Nickles, R. J.; Cai, W. Positron Emission Tomography Imaging of Cd105 Expression with 89zr-Df-Trc105 Eur. J. Nucl. Med. Mol. Imaging 2012, 39, 138-148 10.1007/s00259-011-1930-x
176. Hiraoka, N.; Ino, Y.; Sekine, S.; Tsuda, H.; Shimada, K.; Kosuge, T.; Zavada, J.; Yoshida, M.; Yamada, K.; Koyama, T.; Kanai, Y. Tumour Necrosis Is a Postoperative Prognostic Marker for Pancreatic Cancer Patients with a High Interobserver Reproducibility in Histological Evaluation Br. J. Cancer 2010, 103, 1057-1065 10.1038/sj.bjc.6605854
177. Liu, J. K. The History of Monoclonal Antibody Development-Progress, Remaining Challenges and Future Innovations Ann. Med. Surg (Lond). 2014, 3, 113-116 10.1016/j.amsu.2014.09.001
178. Velpandian, T.; Sharma, C.; Garg, S. P.; Mandal, S.; Ghose, S. Safety and Cost-Effectiveness of Single Dose Dispensing of Bevacizumab for Various Retinal Pathologies in Developing Countries Indian J. Ophthalmol. 2007, 55, 488-490 10.4103/0301-4738.36502
179. Hidalgo, M. New Insights into Pancreatic Cancer Biology Ann. Oncol. 2012, 23 (Suppl. 10) x135-x138 10.1093/annonc/mds313
180. Irie, H.; Honda, H.; Kaneko, K.; Kuroiwa, T.; Yoshimitsu, K.; Masuda, K. Comparison of Helical Ct and Mr Imaging in Detecting and Staging Small Pancreatic Adenocarcinoma Abdom. Imaging. 1997, 22, 429-433 10.1007/s002619900226
181. Francis, I. R. Role of CT and MR in Detection and Staging of Pancreatic Adenocarcinoma Cancer Imaging 2003, 4, 10-14 10.1102/1470-7330.2003.0026
182. Saisho, H.; Yamaguchi, T. Diagnostic Imaging for Pancreatic Cancer: Computed Tomography, Magnetic Resonance Imaging, and Positron Emission Tomography Pancreas 2004, 28, 273-278 10.1097/00006676-200404000-00011
183. Malak, M.; Masuda, D.; Ogura, T.; Imoto, A.; Abdelaal, U. M.; Sabet, E. A.; Abo Dahab, L. H.; Higuchi, K. Yield of Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography for Solid Pancreatic Neoplasms Scand. J. Gastroenterol. 2016, 51 (3) 360-367 10.3109/00365521.2015.1086019
184. Pietryga, J. A.; Morgan, D. E. Imaging Preoperatively for Pancreatic Adenocarcinoma J. Gastrointest. Oncol. 2015, 6, 343-357 10.3978/j.issn.2078-6891.2015.024
185. Tummala, P.; Junaidi, O.; Agarwal, B. Imaging of Pancreatic Cancer: An Overview J. Gastrointest. Oncol. 2011, 2, 168-174 10.3978/j.issn.2078-6891.2011.036
186. Klauss, M.; Maier-Hein, K.; Tjaden, C.; Hackert, T.; Grenacher, L.; Stieltjes, B. IVIM DW-MRI of Autoimmune Pancreatitis: Therapy Monitoring and Differentiation from Pancreatic Cancer Eur. Radiol. 2015, 10.1007/s00330-015-4041-4
187. Serrano, O. K.; Chaudhry, M. A.; Leach, S. D. The Role of Pet Scanning in Pancreatic Cancer Adv. Surg. 2010, 44, 313-325 10.1016/j.yasu.2010.05.007
188. De Paoli, P. Institutional Shared Resources and Translational Cancer Research J. Transl. Med. 2009, 7, 54 10.1186/1479-5876-7-54
189. Sevick-Muraca, E. M.; Akers, W. J.; Joshi, B. P.; Luker, G. D.; Cutler, C. S.; Marnett, L. J.; Contag, C. H.; Wang, T. D.; Azhdarinia, A. Advancing the Translation of Optical Imaging Agents for Clinical Imaging Biomed. Opt. Express 2013, 4, 160-170 10.1364/BOE.4.000160
190. Phillips, E.; Penate-Medina, O.; Zanzonico, P. B.; Carvajal, R. D.; Mohan, P.; Ye, Y.; Humm, J.; Gonen, M.; Kalaigian, H.; Schoder, H.; Strauss, H. W.; Larson, S. M.; Wiesner, U.; Bradbury, M. S. Clinical Translation of an Ultrasmall Inorganic Optical-Pet Imaging Nanoparticle Probe Sci. Transl. Med. 2014, 6, 260ra149 10.1126/scitranslmed.3009524
191. Ntziachristos, V. Clinical Translation of Optical and Optoacoustic Imaging Philos. Trans. R. Soc., A 2011, 369, 4666-4678 10.1098/rsta.2011.0270
192. Roshan, M. V.; Razaghi, S.; Asghari, F.; Rawat, R. S.; Springham, S. V.; Lee, P.; Lee, S.; Tan, T. L. Potential Medical Applications of the Plasma Focus in the Radioisotope Production for Pet Imaging Phys. Lett. A 2014, 378, 2168-2170 10.1016/j.physleta.2014.05.017
193. Muehllehner, G.; Karp, J. S. Positron Emission Tomography Phys. Med. Biol. 2006, 51, R117-137 10.1088/0031-9155/51/13/R08
194. Moses, W. W. Fundamental Limits of Spatial Resolution in PET Nucl. Instrum. Methods Phys. Res., Sect. A 2011, 648 (Suppl. 1) S236-S240 10.1016/j.nima.2010.11.092
195. Surti, S.; Scheuermann, R.; Werner, M. E.; Karp, J. S. Improved Spatial Resolution in Pet Scanners Using Sampling Techniques IEEE Trans. Nucl. Sci. 2009, 56, 596-601 10.1109/TNS.2009.2013389
196. Chaudhary, V.; Bano, S. Imaging of the Pancreas: Recent Advances Indian J. Endocrinol. Metab. 2011, 15, 25-32 10.4103/2230-8210.83060
197. Mitchell, G. S.; Cherry, S. R. A High-Sensitivity Small Animal Spect System Phys. Med. Biol. 2009, 54, 1291-1305 10.1088/0031-9155/54/5/013
198. Ding, H.; Wu, F. Image Guided Biodistribution and Pharmacokinetic Studies of Theranostics Theranostics 2012, 2, 1040-1053 10.7150/thno.4652
199. Key, J.; Leary, J. F. Nanoparticles for Multimodal in Vivo Imaging in Nanomedicine Int. J. Nanomed. 2014, 9, 711-726 10.2147/IJN.S53717
200. Schultz-Sikma, E. A.; Meade, T. J. Supramolecular Chemistry in Biological Imaging in Vivo. In Supramolecular Chemistry; John Wiley & Sons, Ltd: 2012.
201. Stephen, Z. R.; Kievit, F. M.; Zhang, M. Magnetite Nanoparticles for Medical Mr Imaging Mater. Today (Oxford, U. K.) 2011, 14, 330-338 10.1016/S1369-7021(11)70163-8
202. Cai, W. Seeing Is Believing: Molecular Imaging in Living Subjects Curr. Pharm. Biotechnol. 2010, 11, 544 10.2174/138920110792246492
203. Massoud, T. F.; Gambhir, S. S. Molecular Imaging in Living Subjects: Seeing Fundamental Biological Processes in a New Light Genes Dev. 2003, 17, 545-580 10.1101/gad.1047403
204. Lacroix, L. M.; Delpech, F.; Nayral, C.; Lachaize, S.; Chaudret, B. New Generation of Magnetic and Luminescent Nanoparticles for in Vivo Real-Time Imaging Interface Focus 2013, 3, 20120103 10.1098/rsfs.2012.0103
205. Bohndiek, S. E.; Bodapati, S.; Van De Sompel, D.; Kothapalli, S. R.; Gambhir, S. S. Development and Application of Stable Phantoms for the Evaluation of Photoacoustic Imaging Instruments PLoS One 2013, 8, e75533 10.1371/journal.pone.0075533
206. Ku, G.; Wang, L. V. Deeply Penetrating Photoacoustic Tomography in Biological Tissues Enhanced with an Optical Contrast Agent Opt. Lett. 2005, 30, 507-509 10.1364/OL.30.000507
207. Ntziachristos, V. Going Deeper Than Microscopy: The Optical Imaging Frontier in Biology Nat. Methods 2010, 7, 603-614 10.1038/nmeth.1483
208. Zhang, Y.; Jeon, M.; Rich, L. J.; Hong, H.; Geng, J.; Zhang, Y.; Shi, S.; Barnhart, T. E.; Alexandridis, P.; Huizinga, J. D.; Seshadri, M.; Cai, W.; Kim, C.; Lovell, J. F. Non-Invasive Multimodal Functional Imaging of the Intestine with Frozen Micellar Naphthalocyanines Nat. Nanotechnol. 2014, 9, 631-638 10.1038/nnano.2014.130
209. Zhu, X.; Li, J.; Hong, Y.; Kimura, R. H.; Ma, X.; Liu, H.; Qin, C.; Hu, X.; Hayes, T. R.; Benny, P.; Gambhir, S. S.; Cheng, Z. 99mTc-Labeled Cystine Knot Peptide Targeting Integrin Alphavbeta6 for Tumor Spect Imaging Mol. Pharmaceutics 2014, 11, 1208-1217 10.1021/mp400683q
210. Cruz-Monserrate, Z.; Roland, C. L.; Deng, D.; Arumugam, T.; Moshnikova, A.; Andreev, O. A.; Reshetnyak, Y. K.; Logsdon, C. D. Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment Sci. Rep. 2014, 4, 4410 10.1038/srep04410
211. Knoop, K.; Kolokythas, M.; Klutz, K.; Willhauck, M. J.; Wunderlich, N.; Draganovici, D.; Zach, C.; Gildehaus, F. J.; Boning, G.; Goke, B.; Wagner, E.; Nelson, P. J.; Spitzweg, C. Image-Guided, Tumor Stroma-Targeted 131i Therapy of Hepatocellular Cancer after Systemic Mesenchymal Stem Cell-Mediated Nis Gene Delivery Mol. Ther. 2011, 19, 1704-1713 10.1038/mt.2011.93